Blood oxygen level-dependent magnetic resonance imaging (BOLD MRI) has recently been utilized as a noninvasive tool for evaluating renal oxygenation. Several methods have been proposed for analyzing BOLD images. Regional ROI selection is the earliest and most widely used method for BOLD analysis. In the last 20 years, many investigators have used this method to evaluate cortical and medullary oxygenation in patients with ischemic nephropathy, hypertensive nephropathy, diabetic nephropathy, chronic kidney disease (CKD), acute kidney injury and renal allograft rejection. However, clinical trials of BOLD MRI using regional ROI selection revealed that it was difficult to distinguish the renal cortico-medullary zones with this method, and that it was susceptible to observer variability. To overcome these deficiencies, several new methods were proposed for analyzing BOLD images, including the compartmental approach, fractional hypoxia method, concentric objects (CO) method and twelve-layer concentric objects (TLCO) method. The compartmental approach provides an algorithm to judge whether the pixel belongs to the cortex or medulla. Fractional kidney hypoxia, measured by using BOLD MRI, was negatively correlated with renal blood flow, tissue perfusion and glomerular filtration rate (GFR) in patients with atherosclerotic renal artery stenosis. The CO method divides the renal parenchyma into six or twelve layers of thickness in each coronal slice of BOLD images and provides a R2* radial profile curve. The slope of the R2* curve associated positively with eGFR in CKD patients. Indeed, each method invariably has advantages and disadvantages, and there is generally no consensus method so far. Undoubtedly, analytic approaches for BOLD MRI with better reproducibility would assist clinicians in monitoring the degree of kidney hypoxia and thus facilitating timely reversal of tissue hypoxia.

Physiologically, renal tissue works under relative hypoxic conditions, particularly in the deep areas of the medulla. Constant oxygen depletion, microvasculature compromise and inflammation within the renal cortical and medullary zones make the renal parenchyma particularly vulnerable to hypoperfusion and hypoxic injury, leading to interstitial fibrosis and a vicious cycle that ultimately accelerates the progression of kidney disease [1-6]. Considering these factors, it is necessary to determine the degree of renal hypoxia in patients accurately and noninvasively, although many currently established approaches are not used to assess renal tissue oxygenation in vivo because they are invasive.

Blood oxygen level-dependent magnetic resonance imaging (BOLD MRI) is a noninvasive, versatile, safe and reliable technique for evaluating renal tissue oxygenation without exposure to radiation or exogenous contrast agents [7-10], and so this examination can be repeated several times without concern about side effects. It also has a high spatial resolution, making it possible to detect functional changes that have had occurred before the pathological damage of renal tissue and to reflect kidney oxygenation quantitatively. The correlation between signal strength of BOLD MRI and oxygen content of renal tissue was confirmed by direct measurement of oxygen partial pressure with oxygen-sensitive microelectrodes [11-13].

The principle of BOLD MRI is based on the physiology and strong paramagnetic properties of deoxyhemoglobin. Deoxyhemoglobin can cause uneven magnetic field around the regional kidney tissue and shorten the apparent spin relaxation time (T2*) by changing the spin characteristics of the surrounding water molecules. The apparent relaxation rate (R2*) is the inverse of the characteristic T2* relaxation time (R2*=1/T2*), which reflects the tissue deoxyhemoglobin level. As stated previously, R2* is positively correlated with the level of deoxyhemoglobin [14-16]. A higher R2* value in response to hypoxia corresponds to a higher tissue content of deoxyhemoglobin with lower tissue oxygenation, and vice versa. Conventionally, cortical R2* is low, with a gradient increase in R2* values from the cortex to the medulla. The highest R2* value can be recognized in the inner medullary zones, consistent with the established relative hypoxia of this region [17].

Over the last two decades, BOLD MRI has been widely used to assess changes in renal oxygen level in various kidney disease conditions, for instance, ischemic [18], hypertensive [19], diabetic [20-23] and contrast [24-26] nephropathies as well as nephrotic syndrome [27], lupus nephritis [28, 29], chronic kidney disease [30-32], acute kidney injury [33, 34] and renal allograft rejection [35-39]. It is interesting to note that BOLD MRI studies with many analytical methods in patients with different etiologies have shown inconsistent and contradictory results, reporting higher or lower R2* values.

For a better analysis of BOLD images, it has already been verified that increasing magnetic field intensity from 1.5 to 3.0 T demonstrates larger R2* variation and effectively improves the sensitivity and reliability of BOLD [40-42]. Regarding in vivo experiments, the kidney alignment for BOLD renal imaging (KALIBRI) algorithm was recommended to operate three-dimensional (3D) rigid image registration instead of two-dimensional (2D) time-resolved renal BOLD MRI, allowing for consistent R2* detection during breath-holds [43].

Nevertheless, finding a valid and accurate imaging analytical approach that adequately reflects renal tissue oxygenation remains a challenge. This review summarizes current methods applied to BOLD MRI analysis and their advantages and disadvantages (Table 1).

Regional ROI selection

In initial clinical studies, cortical and medullary R2* values were predominantly evaluated separately. Typically, 5-8 mm thick T2*-weighted images of sagittal or coronal slices were acquired during breath-hold with a 1.5 or 3.0 T system and the clearest image was selected with optimal contrast between cortex and medulla. Several regions of interest (ROIs) were then draw within small regions (two or three cortical and medullary ROIs, respectively) through the renal hilum (Fig. 1A). Thus, the mean R2* value for the cortex and medulla of each slice is determined.

Fig. 1.

Two BOLD MRI analysis methods. A) Regional ROI selection: small ROIs are drawn within the cortex (ROIs 1-3) and the medulla (ROIs 4-6) to evaluate cortical and medullary oxygenation, respectively. B) Fractional kidney hypoxia method: the whole kidney zones are drawn including the cortex and medulla to fully assess kidney oxygenation. C) Fractional kidney hypoxia method: ROI is drawn containing a wide cortical area to assess cortical oxygenation.

Fig. 1.

Two BOLD MRI analysis methods. A) Regional ROI selection: small ROIs are drawn within the cortex (ROIs 1-3) and the medulla (ROIs 4-6) to evaluate cortical and medullary oxygenation, respectively. B) Fractional kidney hypoxia method: the whole kidney zones are drawn including the cortex and medulla to fully assess kidney oxygenation. C) Fractional kidney hypoxia method: ROI is drawn containing a wide cortical area to assess cortical oxygenation.

Close modal

This ROIs technique was the earliest classical analytic approach and is still commonly used today. Data from Gloviczki et al. [44] indicate that cortical and medullary oxygenation, as expressed by the R2* values, did not differ in post-stenotic kidneys as compared with contralateral kidneys or kidneys in essential hypertension. The main reason being that oxygen consumption and energy requirements for sodium transport are decreased despite the reduced blood flow and kidney volume in patients with renal artery stenosis. Recent clinical studies showed that average cortical and medullary R2* values are similar in controls, in both hypertensive and CKD patients [45, 46]. Michaely et al. [47] found no correlation between renal tissue oxygenation and estimated glomerular filtration rate (eGFR) or different stages of CKD. Most importantly, these results are inconsistent with other studies involving the ROIs method [48-50] and other analysis methods to be introduced later. This could be because the subjects enrolled in these studies had different disease states, medications, and other physiological mechanisms that may affect the R2* values in BOLD MRI.

The ROI selection has obvious shortcomings that limit its clinical application. On the one hand, ROIs of different sizes manually placed in the cortex and the medulla may affect the accuracy and reproducibility of R2* values. In other words, R2* values are susceptible to observer variability. On the other hand, it is difficult to distinguish renal cortico-medullary zones. Researchers need to draw the ROIs carefully to make their size as similar as possible and reduce the overlap between the cortex and the medulla. Under these circumstances, some nephrologists have replaced circlular ROIs with rectangular ROIs containing both the cortex and the medulla to prevent R2* value variation [28]. However, it is not clear whether the R2* values obtained by this method are reliable and accurate. Considering the above factors, we do not recommend that researchers analyze BOLD images using the regional ROI selection.

Compartmental approach

In general, T2*-weighted MRI images cannot clearly distinguish between the renal cortex and medulla. Small ROIs can be influenced by fluctuations caused by spatial and temporal heterogeneity in renal oxygen distribution, especially in the medulla, even though they are similar in volume [51].

Ebrahimi et al. [52] developed a model to mitigate this challenge, called the compartmental approach, assuming that the cortical and medullary R2* populations fit Gaussian and Gamma distribution, respectively. This new compartmental approach separates the R2* values into two renal compartments (excluding the collecting system, blood vessels, artifacts and cysts) and calculates the mean R2* value for each compartment. Then, it provides distribution curves and affords R2* distribution patterns within these compartments. Based on the distribution of R2* values, this method is independent of orientation and volume change, providing an algorithm to judge whether the pixel belongs to the cortex or medulla.

In recent years, Vink et al. [53] used this method to investigate the effect of renal denervation (RDN) on kidney oxygenation in patients with hypertension. They found no significant changes in renal oxygenation, possibly due to unchanged renal perfusion after RDN and small changes in cortical oxygenation “ignored” by the BOLD MRI procedure, as well as failed RDN procedure in some patients. Moreover, a recent study [54] applied a semi-automated, anatomically unbiased approach, complementary to the compartmental method, to analyze BOLD MRI images. In rats, k-means clustering segregates the whole kidney into two compartments and obviates the need for manual selection of small ROIs. The clustering analysis method shows low R2* clusters localized to the cortex, while the outer medulla demonstrates a higher R2* cluster.

Compared with the manual ROIs method, the relaxivity index R2* obtained using the compartmental approach shows less variability and operator dependency, with improved time-efficiency and reproducibility. Because there is no need for manual ROIs selection, the distribution function-based approach breaks the inherent limitations of choosing ROIs of appropriate size and location. However, it depends on the heterogeneity of medullary oxygenation and is insensitive to the abdominal susceptibility artifact, which must be manually excluded in the analysis. The boundaries between the cortex and medulla may be blurred when the oxygenation of the medulla is approximate to that of the cortex. To date, it is still uncertain whether this method is reliable under different conditions and in other models.

Fractional kidney hypoxia method

Recently, fractional kidney hypoxia was introduced for identifying oxygenation within the renal parenchyma. The large ROI obtained using a freehand tool traces the entire kidney zones encompassing both cortex and medulla, determined by measuring the percentage of the entire axial image section with R2* values above a certain threshold (usually >30 sec-1) (Fig. 1B). In addition, the ROI of the wide cortical area excluding the renal collecting system, cysts, calculus and hilar vessels was placed so as to evaluate cortical oxygenation (Fig. 1C). As described by Saad et al. [55], fractional hypoxia was negatively correlated with renal blood flow, tissue perfusion and GFR compared with regionally selected cortical and medullary segments.

A combination of renal parenchyma and large cortical ROI assessment provides a sensitive and objective method for analyzing renal BOLD MRI data [56]. It has a higher inter-rater agreement than the traditional ROIs method, and greatly simplifies image analysis. Because of the full use of all available slices, fractional kidney hypoxia can marginally reduce the bias resulting from operator selection of ROIs.

Larger ROIs that include the entire kidney may provide more valid and reliable mean R2* values, but often contain cortico-medullary overlap zones as well as the deepest most hypoxic sections of the medulla [51]. This method of analysis also could not solve the inherent sampling problem owing to it only sampling one part of the kidney. Furthermore, it might be argued that the choice of R2* values above 30 sec-1 as the threshold of hypoxia was arbitrary and could not be applied to different magnetic field strengths and other renal disease. To gain more flexibility in future studies, it is requisite to select the threshold relative to the mean cortical R2* or the cortical and medullary R2* ratio [57].

Concentric objects method

Recent publications proposed a new semi-automated “concentric objects” (CO) method (or “onion peel” method) for analyzing BOLD images. Corresponding R2* maps were acquired with four coronal slices and then the renal parenchyma was semi-automatically divided into six layers of equal thickness by the program. The investigators then sketched the contours of the outer (cortical side) and inner (medullary side) border of the renal parenchyma manually and reported the R2* values of all six layers. The layers comprised the cortex, medulla, or a combination of both. When repeating the examination, layers can be traced at the same depth. Studies performed by Piskunowicz et al. [58] showed that the CO method, compared with the classical ROIs method, showed excellent reproducibility and lower inter-observer variability in all tested layers of the kidney in both non-CKD and CKD groups.

Nevertheless, the CO method must be applied to oval-shaped kidneys. In addition, blood vessels, cysts, tumors, artifacts and the urine-containing renal pelvis are difficult to be excluded. The relatively limited number of layers hinders the acquisition of sequential changes in R2* values. Therefore, this technique is devoid of precision although it can reduce operator bias considerably. Further clinical and animal experiments are necessary to evaluate the exact quantity of cortical and medullary areas per layer with this method.

Twelve-layer concentric objects method

To overcome the limitations inherent in the CO method, Milani et al. [59] developed the twelve-layer concentric objects (TLCO) method based on the CO method. The TLCO method divides the renal parenchyma into twelve layers of equal thickness in each coronal slice by using a locally automated procedure. Investigators evaluated the concentric objects in three dimensions. The collection of four voxels at a constant depth in the renal parenchyma were designated CO3D. So, there are four slices, twelve layers in each slice, and twelve CO3D within each kidney, in this method.

This automated technique successfully provides a means for monitoring the mean R2* value of each layer by obtaining the average of the R2* values in each of the twelve CO3Ds. Instead of absolute R2* values, a R2* radial profile curve is drawn, defining the percent of equal relative depth (ranging from 0% to 100%) as the x-axis and the mean R2* of each CO3D as the y-axis. The R2* changes in successive layers from superficial to deeper renal tissue was obtained by calculating the steepness of the relevant curve. From this study, the R2* value increased significantly in the outer layers and the largest change in R2* is seen in the deeper layers, suggesting lower kidney oxygenation, more pronounced in the medulla. The slope of the R2* curve associated positively with eGFR in CKD patients, which means that the higher the eGFR of patients, the steeper the corresponding R2* slope.

This optimal TLCO method is independent of observer-selection and focuses more on intra-compartmental distribution rather than mean R2* values. It makes full use of the geometry of the whole renal parenchyma and provides detailed layer-by-layer information, making it more sensitive to small changes in R2* values. Briefly, compared with the classical ROIs and CO methods, the TLCO method improves the accuracy of distinguishing the cortex and medulla of the kidney and is more sensitive to evidence of small changes in renal R2* values during administration of renin inhibitors and diuretics [60].

Although, the R2* slope was selected as a marker of cortico-medullary differentiation, it still directly depends on the observer’s manual choice of the inner profile of the renal parenchyma. Nevertheless, compared with the CO method, the TLCO technique has twice the number of layers, however, whether twelve layers is most appropriate to accurately reflect the difference between layers and the sequent R2* changes is uncertain. Thus, more investigation is needed to demonstrate how many onion peel-like layers are most suitable for this method.

It is a prerequisite that BOLD MRI analysis reflects tissue oxygenation and that tissue and blood oxygen levels are in equilibrium. However, some studies have indeed demonstrated that kidney vascular oxygenation and tissue oxygenation may actually vary [61, 62].

As a result of the strong positive magnetic susceptibility of deoxyhemoglobin, the R2* value is easily affected. Additionally, several factors other than deoxyhemoglobin also can influence R2* values, such as hydration status, renal blood flow, blood PH, hematocrit, sodium intake, susceptibility effects and vascular volume [50, 63-67]. Some investigators suggest that spatial distribution of local static magnetic field heterogeneity and susceptible abdominal artifacts due to respiratory and air-filled colonic loop movement largely limit the clinical application of BOLD MRI. Intake of drugs by patients before BOLD MRI examination, such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers [68-71], beta blockers [72] or diuretics [45, 73-75], could confound the use of BOLD MRI in measuring renal oxygenation as a result of increasing oxygen delivery and reducing oxygen consumption. Nonetheless, it is indeed challenging to remove and eliminate the effects of all drugs that affect renal oxygenation particularly in subjects in need of blood pressure control in the clinical setting.

The main shortcoming of all currently available BOLD MRI analysis methods is the absence of cortico-medullary differentiation, resulting in difficulties in manual tracing of appropriate ROIs. The aforementioned study by Milani et al. [59] supports the concept of BOLD MRI combined with blood flow-based MRI techniques, such as arterial spin labelling, which may potentially help to distinguish the cortico-medullary zones in the future.

The apparent diffusion coefficient (ADC) in diffusion weighted MRI (DW-MRI) offers a non-invasive way to quantify renal fibrosis and microcirculation [49, 63, 76-78]. It has previously been shown that reduction in ADC is demonstrably related to degree of fibrosis, CKD and lupus staging [79-81]. BOLD MRI combined with DW-MRI, are capable of early identifying decline of renal function, however, further investigation is still required.

Numerous techniques have been used to analyze BOLD MRI, but there is still no unified standard method so far. The disadvantages mentioned above limit its clinical application. We believe that further exploration of new methods of BOLD MRI analysis will improve evaluation sensitivity. BOLD MRI can detect changes in intra-renal oxygen metabolism before any irreversible damage occurs in the renal parenchyma and interstitium.

The authors of this manuscript state that they do not have any Disclosure Statements.

This study has received funding from the National Natural Science Foundation of China (81270769); Jiangsu Provincial Natural Science Foundation (BK20161172); Jiangsu Provincial Commission of Health and Family Planning (2016103003); Qing Lan of Jiangsu Province; Liu Ge Yi of Jiangsu Province; Liu Da Ren Cai Gao Feng of Jiangsu Province, China (2010-WS043); the Technology Development Foundation of Kuitun City (201134); Jiangsu Overseas Training Program for University Prominent Young & Middle-aged Teachers and Presidents; and Shi Er Wu Ke Jiao Xing Wei Key Medical Personnel of Jiangsu Province (RC2011116).

1.
Hirakawa Y, Tanaka T, Nangaku M: Renal Hypoxia in CKD; Pathophysiology and Detecting Methods. Front Physiol 2017; 8: 99.
2.
Tanaka S, Tanaka T, Nangaku M: Hypoxia as a key player in the AKI-to-CKD transition. Am J Physiol Renal Physiol 2014; 307:F1187-1195.
3.
Shoji K, Tanaka T, Nangaku M: Role of hypoxia in progressive chronic kidney disease and implications for therapy. Curr Opin Nephrol Hypertens 2014; 23: 161-168.
4.
Haase VH: Mechanisms of hypoxia responses in renal tissue. J Am Soc Nephrol 2013; 24: 537-541.
5.
Neugarten J: Renal BOLD-MRI and assessment for renal hypoxia. Kidney Int 2012; 81: 613-614.
6.
Heyman SN, Khamaisi M, Rosen S, Rosenberger C: Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 2008; 28: 998-1006.
7.
Ebrahimi B, Textor SC, Lerman LO: Renal relevant radiology: renal functional magnetic resonance imaging. Clin J Am Soc Nephrol 2014; 9: 395-405.
8.
Chrysochou C, Mendichovszky IA, Buckley DL, Cheung CM, Jackson A, Kalra PA: BOLD imaging: a potential predictive biomarker of renal functional outcome following revascularization in atheromatous renovascular disease. Nephrol Dial Transplant 2012; 27: 1013-1019.
9.
Chandarana H, Lee VS: Renal functional MRI: Are we ready for clinical application? AJR Am J Roentgenol 2009; 192: 1550-1557.
10.
Textor SC, Glockner JF, Lerman LO, Misra S, McKusick MA, Riederer SJ, Grande JP, Gomez SI, Romero JC: The use of magnetic resonance to evaluate tissue oxygenation in renal artery stenosis. J Am Soc Nephrol 2008; 19: 780-788.
11.
Pohlmann A, Arakelyan K, Hentschel J, Cantow K, Flemming B, Ladwig M, Waiczies S, Seeliger E, Niendorf T: Detailing the relation between renal T2* and renal tissue pO2 using an integrated approach of parametric magnetic resonance imaging and invasive physiological measurements. Invest Radiol 2014; 49: 547-560.
12.
Pedersen M, Dissing TH, Morkenborg J, Stodkilde-Jorgensen H, Hansen LH, Pedersen LB, Grenier N, Frokiaer J: Validation of quantitative BOLD MRI measurements in kidney: application to unilateral ureteral obstruction. Kidney Int 2005; 67: 2305-2312.
13.
Juillard L, Lerman LO, Kruger DG, Haas JA, Rucker BC, Polzin JA, Riederer SJ, Romero JC: Blood oxygen level-dependent measurement of acute intra-renal ischemia. Kidney Int 2004; 65: 944-950.
14.
Niles DJ, Gordon JW, Fain SB: Effect of anesthesia on renal R2 * measured by blood oxygen level-dependent MRI. NMR Biomed 2015; 28: 811-817.
15.
Warner L, Glockner JF, Woollard J, Textor SC, Romero JC, Lerman LO: Determinations of renal cortical and medullary oxygenation using blood oxygen level-dependent magnetic resonance imaging and selective diuretics. Invest Radiol 2011; 46: 41-47.
16.
Prasad PV, Edelman RR, Epstein FH: Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation 1996; 94: 3271-3275.
17.
Zheng Z, Shi H, Ma H, Li F, Zhang J, Zhang Y: Renal Oxygenation Characteristics in Healthy Native Kidneys: Assessment with Blood Oxygen Level-Dependent Magnetic Resonance Imaging. Nephron Physiol 2014; 128: 47-54.
18.
Gloviczki ML, Glockner JF, Crane JA, McKusick MA, Misra S, Grande JP, Lerman LO, Textor SC: Blood oxygen level-dependent magnetic resonance imaging identifies cortical hypoxia in severe renovascular disease. Hypertension 2011; 58: 1066-1072.
19.
Gloviczki ML, Lerman LO, Textor SC: Blood oxygen level-dependent (BOLD) MRI in renovascular hypertension. Curr Hypertens Rep 2011; 13: 370-377.
20.
Pruijm M, Hofmann L, Zanchi A, Maillard M, Forni V, Muller ME, Wuerzner G, Vogt B, Stuber M, Burnier M: Blockade of the renin-angiotensin system and renal tissue oxygenation as measured with BOLD-MRI in patients with type 2 diabetes. Diabetes Res Clin Pract 2013; 99: 136-144.
21.
Yin WJ, Liu F, Li XM, Yang L, Zhao S, Huang ZX, Huang YQ, Liu RB: Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. Eur J Radiol 2012; 81: 1426-1431.
22.
Wang ZJ, Kumar R, Banerjee S, Hsu CY: Blood oxygen level-dependent (BOLD) MRI of diabetic nephropathy: preliminary experience. J Magn Reson Imaging 2011; 33: 655-660.
23.
Prasad P, Li LP, Halter S, Cabray J, Ye M, Batlle D: Evaluation of renal hypoxia in diabetic mice by BOLD MRI. Invest Radiol 2010; 45: 819-822.
24.
Li LP, Lu J, Zhou Y, Papadopoulou MV, Franklin T, Bokhary U, Solomon R, Sen A, Prasad PV: Evaluation of intrarenal oxygenation in iodinated contrast-induced acute kidney injury-susceptible rats by blood oxygen level-dependent magnetic resonance imaging. Invest Radiol 2014; 49: 403-410.
25.
Li LP, Thacker J, Lu J, Franklin T, Zhou Y, Papadopoulou MV, Solomon R, Prasad PV: Efficacy of preventive interventions for iodinated contrast-induced acute kidney injury evaluated by intrarenal oxygenation as an early marker. Invest Radiol 2014; 49: 647-652.
26.
Li LP, Franklin T, Du H, Papadopoulou-Rosenzweig M, Carbray J, Solomon R, Prasad PV: Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: effect of the viscosity and dose. J Magn Reson Imaging 2012; 36: 1162-1167.
27.
Zhang R, Wang Y, Chen F, Wang Q, Wang Z, Chen Y, Xiao W: Noninvasive evaluation of renal oxygenation in primary nephrotic syndrome with blood oxygen level dependent magnetic resonance imaging: Initial experience. J Int Med Res 2015; 43: 356-363.
28.
Shi H, Yan T, Li D, Jia J, Shang W, Wei L, Zheng Z: Detection of Renal Hypoxia in Lupus Nephritis Using Blood Oxygen Level-Dependent MR Imaging: A Multiple Correspondence Analysis. Kidney Blood Press Res 2017; 42: 123-135.
29.
Shi H, Jia J, Li D, Wei L, Shang W, Zheng Z: Blood oxygen level-dependent magnetic resonance imaging for detecting pathological patterns in patients with lupus nephritis: a preliminary study using gray-level cooccurrence matrix analysis. J Int Med Res 2018; 46: 204-218.
30.
Neugarten J, Golestaneh L: Blood oxygenation level-dependent MRI for assessment of renal oxygenation. Int J Nephrol Renovasc Dis 2014; 7: 421-435.
31.
Xin-Long P, Jing-Xia X, Jian-Yu L, Song W, Xin-Kui T: A preliminary study of blood-oxygen-level-dependent MRI in patients with chronic kidney disease. Magn Reson Imaging 2012; 30: 330-335.
32.
Pruijm M, Ponte B, Hofmann L, Vogt B, Eisenberger U, Meuwly JY, Burnier M: [New radiological techniques to investigate patients suffering from chronic kidney disease]. Rev Med Suisse 2011; 7: 505-509.
33.
Pohlmann A, Arakelyan K, Seeliger E, Niendorf T: Magnetic Resonance Imaging (MRI) Analysis of Ischemia/ Reperfusion in Experimental Acute Renal Injury. Methods Mol Biol 2016; 1397: 113-127.
34.
Bauer F, Wald J, Bauer FJ, Dahlkamp LM, Seibert FS, Pagonas N, Gedat E, Babel N, Zidek W, von Bodman C, Noldus J, Liermann D, Westhoff TH: Detection of Acute Tubular Necrosis Using Blood Oxygenation Level-Dependent (BOLD) MRI. Kidney Blood Press Res 2017; 42: 1078-1089.
35.
Seif M, Eisenberger U, Binser T, Thoeny HC, Krauer F, Rusch A, Boesch C, Vogt B, Vermathen P: Renal Blood Oxygenation Level-dependent Imaging in Longitudinal Follow-up of Donated and Remaining Kidneys. Radiology 2016; 279: 795-804.
36.
Park SY, Kim CK, Park BK, Kim SJ, Lee S, Huh W: Assessment of early renal allograft dysfunction with blood oxygenation level-dependent MRI and diffusion-weighted imaging. Eur J Radiol 2014; 83: 2114-2121.
37.
Liu G, Han F, Xiao W, Wang Q, Xu Y, Chen J: Detection of renal allograft rejection using blood oxygen level-dependent and diffusion weighted magnetic resonance imaging: a retrospective study. BMC Nephrol 2014; 15: 158.
38.
Park SY, Kim CK, Park BK, Huh W, Kim SJ, Kim B: Evaluation of transplanted kidneys using blood oxygenation level-dependent MRI at 3 T: a preliminary study. AJR Am J Roentgenol 2012; 198: 1108-1114.
39.
Sadowski EA, Djamali A, Wentland AL, Muehrer R, Becker BN, Grist TM, Fain SB: Blood oxygen level-dependent and perfusion magnetic resonance imaging: detecting differences in oxygen bioavailability and blood flow in transplanted kidneys. Magn Reson Imaging 2010; 28: 56-64.
40.
Gloviczki ML, Glockner J, Gomez SI, Romero JC, Lerman LO, McKusick M, Textor SC: Comparison of 1.5 and 3 T BOLD MR to study oxygenation of kidney cortex and medulla in human renovascular disease. Invest Radiol 2009; 44: 566-571.
41.
Tumkur S, Vu A, Li L, Prasad PV: Evaluation of intrarenal oxygenation at 3.0 T using 3-dimensional multiple gradient-recalled echo sequence. Invest Radiol 2006; 41: 181-184.
42.
Li LP, Vu AT, Li BS, Dunkle E, Prasad PV: Evaluation of intrarenal oxygenation by BOLD MRI at 3.0 T. J Magn Reson Imaging 2004; 20: 901-904.
43.
Kalis IM, Pilutti D, Krafft AJ, Hennig J, Bock M: Prospective MR image alignment between breath-holds: Application to renal BOLD MRI. Magn Reson Med 2017; 77: 1573-1582.
44.
Gloviczki ML, Glockner JF, Lerman LO, McKusick MA, Misra S, Grande JP, Textor SC: Preserved oxygenation despite reduced blood flow in poststenotic kidneys in human atherosclerotic renal artery stenosis. Hypertension 2010; 55: 961-966.
45.
Pruijm M, Hofmann L, Piskunowicz M, Muller ME, Zweiacker C, Bassi I, Vogt B, Stuber M, Burnier M: Determinants of renal tissue oxygenation as measured with BOLD-MRI in chronic kidney disease and hypertension in humans. PLoS One 2014; 9:e95895.
46.
Khatir DS, Pedersen M, Jespersen B, Buus NH: Evaluation of Renal Blood Flow and Oxygenation in CKD Using Magnetic Resonance Imaging. Am J Kidney Dis 2015; 66: 402-411.
47.
Michaely HJ, Metzger L, Haneder S, Hansmann J, Schoenberg SO, Attenberger UI: Renal BOLD-MRI does not reflect renal function in chronic kidney disease. Kidney Int 2012; 81: 684-689.
48.
Inoue T, Kozawa E, Okada H, Suzuki H: Is there no future for renal BOLD-MRI? Kidney Int 2012; 82: 934.
49.
Inoue T, Kozawa E, Okada H, Inukai K, Watanabe S, Kikuta T, Watanabe Y, Takenaka T, Katayama S, Tanaka J, Suzuki H: Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. J Am Soc Nephrol 2011; 22: 1429-1434.
50.
Prasad PV, Thacker J, Li LP, Haque M, Li W, Koenigs H, Zhou Y, Sprague SM: Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study. PLoS One 2015; 10:e0139661.
51.
Gloviczki ML, Saad A, Textor SC: Blood oxygen level-dependent (BOLD) MRI analysis in atherosclerotic renal artery stenosis. Curr Opin Nephrol Hypertens 2013; 22: 519-524.
52.
Ebrahimi B, Gloviczki M, Woollard JR, Crane JA, Textor SC, Lerman LO: Compartmental analysis of renal BOLD MRI data: introduction and validation. Invest Radiol 2012; 47: 175-182.
53.
Vink EE, Boer A, Verloop WL, Spiering W, Voskuil M, Vonken E, Hoogduin JM, Leiner T, Bots ML, Blankestijn PJ: The effect of renal denervation on kidney oxygenation as determined by BOLD MRI in patients with hypertension. Eur Radiol 2015; 25: 1984-1992.
54.
Menzies RI, Zammit-Mangion A, Hollis LM, Lennen RJ, Jansen MA, Webb DJ, Mullins JJ, Dear JW, Sanguinetti G, Bailey MA: An anatomically unbiased approach for analysis of renal BOLD magnetic resonance images. Am J Physiol Renal Physiol 2013; 305:F845-852.
55.
Saad A, Crane J, Glockner JF, Herrmann SM, Friedman H, Ebrahimi B, Lerman LO, Textor SC: Human renovascular disease: estimating fractional tissue hypoxia to analyze blood oxygen level-dependent MR. Radiology 2013; 268: 770-778.
56.
Thacker JM, Li LP, Li W, Zhou Y, Sprague SM, Prasad PV: Renal Blood Oxygenation Level-Dependent Magnetic Resonance Imaging: A Sensitive and Objective Analysis. Invest Radiol 2015; 50: 821-827.
57.
Zhang JL, Morrell GR, Lee VS: Blood oxygen level-dependent MR in renal disease: moving toward clinical utility. Radiology 2013; 268: 619-621.
58.
Piskunowicz M, Hofmann L, Zuercher E, Bassi I, Milani B, Stuber M, Narkiewicz K, Vogt B, Burnier M, Pruijm M: A new technique with high reproducibility to estimate renal oxygenation using BOLD-MRI in chronic kidney disease. Magn Reson Imaging 2015; 33: 253-261.
59.
Milani B, Ansaloni A, Sousa-Guimaraes S, Vakilzadeh N, Piskunowicz M, Vogt B, Stuber M, Burnier M, Pruijm M: Reduction of cortical oxygenation in chronic kidney disease: evidence obtained with a new analysis method of blood oxygenation level-dependent magnetic resonance imaging. Nephrol Dial Transplant 2017; 32: 2097-2105.
60.
Vakilzadeh N, Muller ME, Forni V, Milani B, Hoffman L, Piskunowicz M, Maillard M, Zweiacker C, Pruijm M, Burnier M: Comparative Effect of a Renin Inhibitor and a Thiazide Diuretic on Renal Tissue Oxygenation in Hypertensive Patients. Kidney Blood Press Res 2015; 40: 542-554.
61.
Pruijm M, Hofmann L, Vogt B, Muller ME, Piskunowicz M, Stuber M, Burnier M: Renal tissue oxygenation in essential hypertension and chronic kidney disease. Int J Hypertens 2013; 2013: 696598.
62.
Evans RG, Leong CL, Anderson WP, O’Connor PM: Don’t be so BOLD: potential limitations in the use of BOLD MRI for studies of renal oxygenation. Kidney Int 2007; 71: 1327-1328.
63.
Pruijm M, Milani B, Burnier M: Blood Oxygenation Level-Dependent MRI to Assess Renal Oxygenation in Renal Diseases: Progresses and Challenges. Front Physiol 2016; 7: 667.
64.
Niendorf T, Pohlmann A, Arakelyan K, Flemming B, Cantow K, Hentschel J, Grosenick D, Ladwig M, Reimann H, Klix S, Waiczies S, Seeliger E: How bold is blood oxygenation level-dependent (BOLD) magnetic resonance imaging of the kidney? Opportunities, challenges and future directions. Acta Physiol (Oxf) 2015; 213: 19-38.
65.
Fine LG, Dharmakumar R: Limitations of BOLD-MRI for assessment of hypoxia in chronically diseased human kidneys. Kidney Int 2012; 82: 934-935.
66.
Pedersen M, Laustsen C, Perot V, Basseau F, Moonen C, Grenier N: Renal hemodynamics and oxygenation in transient renal artery occluded rats evaluated with iron-oxide particles and oxygenation-sensitive imaging. Z Med Phys 2010; 20: 134-142.
67.
Pruijm M, Hofmann L, Maillard M, Tremblay S, Glatz N, Wuerzner G, Burnier M, Vogt B: Effect of sodium loading/depletion on renal oxygenation in young normotensive and hypertensive men. Hypertension 2010; 55: 1116-1122.
68.
van der Bel R, Coolen BF, Nederveen AJ, Potters WV, Verberne HJ, Vogt L, Stroes ES, Krediet CT: Magnetic Resonance Imaging-Derived Renal Oxygenation and Perfusion During Continuous, Steady-State Angiotensin-II Infusion in Healthy Humans. J Am Heart Assoc 2016; 5:e003185.
69.
Vink EE, de Boer A, Hoogduin HJ, Voskuil M, Leiner T, Bots ML, Joles JA, Blankestijn PJ: Renal BOLD-MRI relates to kidney function and activity of the renin-angiotensin-aldosterone system in hypertensive patients. J Hypertens 2015; 33: 597-603.
70.
Siddiqi L, Hoogduin H, Visser F, Leiner T, Mali WP, Blankestijn PJ: Inhibition of the renin-angiotensin system affects kidney tissue oxygenation evaluated by magnetic resonance imaging in patients with chronic kidney disease. J Clin Hypertens (Greenwich) 2014; 16: 214-218.
71.
Stein A, Goldmeier S, Voltolini S, Setogutti E, Feldman C, Figueiredo E, Eick R, Irigoyen M, Rigatto K: Renal oxygen content is increased in healthy subjects after angiotensin-converting enzyme inhibition. Clinics (Sao Paulo) 2012; 67: 761-765.
72.
Hall ME, Rocco MV, Morgan TM, Hamilton CA, Jordan JH, Edwards MS, Hall JE, Hundley WG: Beta-Blocker Use Is Associated with Higher Renal Tissue Oxygenation in Hypertensive Patients Suspected of Renal Artery Stenosis. Cardiorenal Med 2016; 6: 261-268.
73.
Hall ME, Rocco MV, Morgan TM, Hamilton CA, Edwards MS, Jordan JH, Hurie JB, Hundley WG: Chronic diuretic therapy attenuates renal BOLD magnetic resonance response to an acute furosemide stimulus. J Cardiovasc Magn Reson 2014; 16: 17.
74.
Khatir DS, Pedersen M, Jespersen B, Buus NH: Reproducibility of MRI renal artery blood flow and BOLD measurements in patients with chronic kidney disease and healthy controls. J Magn Reson Imaging 2014; 40: 1091-1098.
75.
Epstein FH, Prasad P: Effects of furosemide on medullary oxygenation in younger and older subjects. Kidney Int 2000; 57: 2080-2083.
76.
Yamada K, Shinmoto H, Oshio K, Ito S, Kumagai H, Kaji T: Diffusion-weighted MR Imaging for the Assessment of Renal Function: Analysis Using Statistical Models Based on Truncated Gaussian and Gamma Distributions. Magn Reson Med Sci 2016; 15: 237-245.
77.
Togao O, Doi S, Kuro-o M, Masaki T, Yorioka N, Takahashi M: Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction. Radiology 2010; 255: 772-780.
78.
Thoeny HC, Grenier N: Science to practice: Can diffusion-weighted MR imaging findings be used as biomarkers to monitor the progression of renal fibrosis? Radiology 2010; 255: 667-668.
79.
Li X, Xu X, Zhang Q, Ren H, Zhang W, Liu Y, Yan F, Chen N: Diffusion weighted imaging and blood oxygen level-dependent MR imaging of kidneys in patients with lupus nephritis. J Transl Med 2014; 12: 295.
80.
Zhao J, Wang ZJ, Liu M, Zhu J, Zhang X, Zhang T, Li S, Li Y: Assessment of renal fibrosis in chronic kidney disease using diffusion-weighted MRI. Clin Radiol 2014; 69: 1117-1122.
81.
Xu X, Fang W, Ling H, Chai W, Chen K: Diffusion-weighted MR imaging of kidneys in patients with chronic kidney disease: initial study. Eur Radiol 2010; 20: 978-983.
Open Access License / Drug Dosage / Disclaimer
This article is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND). Usage and distribution for commercial purposes as well as any distribution of modified material requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.